Ernexa Therapeutics Inc.ERNANASDAQ
Loading
Debt to Assets Over TimeCompressed
Percentile Rank11
3Y CAGR+14.5%
5Y CAGR-20.1%
Year-over-Year Change
Debt-to-assets ratio
3Y CAGR
+14.5%/yr
vs -28.3%/yr prior
5Y CAGR
-20.1%/yr
Recent acceleration
Acceleration
+42.8pp
Accelerating
Percentile
P11
Within normal range
vs 5Y Ago
0.3x
Contraction
Streak
1 yr
Consecutive declineCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2024 | 0.13 | -84.8% |
| 2023 | 0.85 | +358.5% |
| 2022 | 0.19 | +115.0% |
| 2021 | 0.09 | -61.5% |
| 2020 | 0.22 | -43.6% |
| 2019 | 0.40 | +55.1% |
| 2018 | 0.26 | -21.3% |
| 2017 | 0.33 | -34.4% |
| 2016 | 0.50 | +9.3% |
| 2015 | 0.45 | - |